DB133 Gene: Potential Drug Target for Breast Cancer (G403339)

Target Name: DEFB133

NCBI ID: G403339

DEFB133

DB133 Gene: Potential Drug Target for Breast Cancer

DEFB133 (DB133_HUMAN), also known as human exploratory breast cancer gene 133, is a gene that is closely related to the occurrence and development of breast cancer. At present, researchers have discovered its important role in the diagnosis, prediction and treatment of breast cancer, so it is considered a potential drug target in the field of future breast cancer treatment.

Mechanism of action of DB133 gene

The DB133 gene is located in the 1p36.1 region of human chromosome and is a member of the breast cancer-related gene family. Studies have found that variations in the DB133 gene are positively correlated with the onset and invasion of breast cancer. In addition, the expression level of DB133 gene is also related to the survival rate of breast cancer patients.

Expression and function of DB133 gene

The expression level of the DB133 gene can be regulated in a variety of ways, including gene expression regulation, DNA methylation, etc. Some studies have found that the expression level of the DB133 gene is positively correlated with the survival rate of breast cancer patients, which means that the DB133 gene may be a potential therapeutic target for breast cancer.

Pharmacological significance of DB133 gene

The DB133 gene is considered a potential drug target in the field of future breast cancer treatment because it is closely related to the occurrence and development of breast cancer. Because of the role of the DB133 gene in breast cancer, researchers are exploring the development of drugs that target the DB133 gene. These drugs can be used to treat breast cancer, including surgery, radiation therapy, chemotherapy and targeted therapy.

Clinical application of DB133 gene

The clinical application of DB133 gene mainly includes the diagnosis, prediction and treatment of breast cancer. First, the DB133 gene can be used as a tumor sample for breast cancer detection and diagnosis. Secondly, the DB133 gene can also be used as a prognostic indicator for breast cancer patients. Doctors can predict the survival rate of patients based on the level of the DB133 gene. Finally, the DB133 gene can also be used as a target for breast cancer treatment, and researchers are exploring the development of targeted therapeutic drugs to attack the DB133 gene.

Biological significance of DB133 gene

The biological significance of the DB133 gene is mainly reflected in the occurrence and progression of breast cancer. Studies have found that variations in the DB133 gene are positively correlated with the incidence and invasiveness of breast cancer, which means that the DB133 gene may be an important factor in the pathogenesis of breast cancer. In addition, the expression level of DB133 gene is also related to the survival rate of breast cancer patients, which means that DB133 gene may be an important target for breast cancer treatment.

Summarize

The DB133 gene is a gene closely related to the occurrence and development of breast cancer. Currently, the DB133 gene has become a hot research topic in the field of breast cancer treatment. Researchers are exploring the development of targeted therapeutic drugs to attack the DB133 gene to treat breast cancer. In the future, the DB133 gene is expected to become an important drug target in the field of breast cancer treatment.

Protein Name: Defensin Beta 133 (pseudogene)

Functions: Has antibacterial activity

The "DEFB133 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about DEFB133 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets